Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Glenmark Pharmaceuticals grants sanofi-aventis license for GBR-500

May 17, 2011

Merus Labs acquires Vancocin from Iroko Pharmaceuticals

May 17, 2011

Clavis Pharma licenses anticancer candidate CP-4033 to Translational Therapeutics

May 16, 2011

Proteomika licenses HuCAL antibodies from AbD Serotec for use in Promonitor diagnostic kits

May 16, 2011

Tourette Syndrome Association and Psyadon Pharmaceuticals collaborate on ecopipam

May 16, 2011

BioFocus and Astellas Pharma sign target discovery agreement for CNS disorders

May 13, 2011

Halozyme and ViroPharma sign agreement to develop subcutaneous Cinryze formulation

May 12, 2011

Takeda acquires exclusive rights to fomepizole in Japan from Paladin Labs

May 11, 2011

Allos Therapeutics and Mundipharma to codevelop anticancer drug Folotyn

May 11, 2011

Sosei gains Japanese rights to antifungal agent Loramyc from BioAlliance

May 11, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...